top of page
Search
Jocelyn Givens on Rheumatology.org
1 min read
Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency
The American College of Rheumatology (ACR) today praised the Food and Drug Administration (FDA) for issuing draft guidance requiring...
By David McNamee/medicalnewstoday.com
6 min read
How does the FDA 'approve' medical products?
You may have seen medical products that claim to be "FDA cleared," "FDA registered," "FDA listed" or "FDA approved" - but what do these...
bottom of page